PTLF (Petlife Pharmaceuticals) OCF Margin %: 0.00% (As of Feb. 2018)


What is Petlife Pharmaceuticals OCF Margin %?

Petlife Pharmaceuticals PTLF OCF Margin % is 0.00% as of Feb. 2018.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Petlife Pharmaceuticals's Cash Flow from Operations for the three months ended in Feb. 2018 was $-0.16 Mil. Petlife Pharmaceuticals's Revenue for the three months ended in Feb. 2018 was $0.00 Mil. Therefore, Petlife Pharmaceuticals's OCF Margin % for the quarter that ended in Feb. 2018 was 0.00%.

As of today, Petlife Pharmaceuticals's current OCF Yield % is -1,310.00%.

The historical rank and industry rank for Petlife Pharmaceuticals's OCF Margin % or its related term are showing as below:


PTLF's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.95
* Ranked among companies with meaningful OCF Margin % only.

Petlife Pharmaceuticals OCF Margin % Related Terms

Petlife Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals OCF Margin % Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Petlife Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Petlife Pharmaceuticals's OCF Margin for the fiscal year that ended in Aug. 2017 is calculated as

OCF Margin=Cash Flow from Operations (A: Aug. 2017 )/Revenue (A: Aug. 2017 )
=-0.319/0
= %

Petlife Pharmaceuticals's OCF Margin for the quarter that ended in Feb. 2018 is calculated as

OCF Margin=Cash Flow from Operations (Q: Feb. 2018 )/Revenue (Q: Feb. 2018 )
=-0.162/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Petlife Pharmaceuticals (PTLF) has a OCF Margin % of 0.00% as of Feb. 2018. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' OCF Margin % too high?
Petlife Pharmaceuticals' current OCF Margin % is 0.00%.
How does Petlife Pharmaceuticals' OCF Margin % compare to PCYN and YBAO?
Petlife Pharmaceuticals' OCF Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Petlife Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Petlife Pharmaceuticals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current OCF Margin % is 0.00% as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.